BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 16956601)

  • 1. Molecular mechanisms of insulin resistance and associated diseases.
    Mlinar B; Marc J; Janez A; Pfeifer M
    Clin Chim Acta; 2007 Jan; 375(1-2):20-35. PubMed ID: 16956601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic syndrome: metabolic changes with vascular consequences.
    Wassink AM; Olijhoek JK; Visseren FL
    Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance in obesity as the underlying cause for the metabolic syndrome.
    Gallagher EJ; Leroith D; Karnieli E
    Mt Sinai J Med; 2010; 77(5):511-23. PubMed ID: 20960553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Insulin resistance and adipose tissue gene expression in humans].
    Bastard JP
    Ann Biol Clin (Paris); 2004; 62(1):25-31. PubMed ID: 15047487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic stress in insulin's target cells leads to ROS accumulation - a hypothetical common pathway causing insulin resistance.
    Eriksson JW
    FEBS Lett; 2007 Jul; 581(19):3734-42. PubMed ID: 17628546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic implications of dietary trans-fatty acids.
    Dorfman SE; Laurent D; Gounarides JS; Li X; Mullarkey TL; Rocheford EC; Sari-Sarraf F; Hirsch EA; Hughes TE; Commerford SR
    Obesity (Silver Spring); 2009 Jun; 17(6):1200-7. PubMed ID: 19584878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Leptin to adiponectin ratio, as an index of insulin resistance and atherosclerosis development].
    Kieć-Klimczak M; Malczewska-Malec M; Huszno B
    Przegl Lek; 2008; 65(12):844-9. PubMed ID: 19441676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
    Corbould A
    Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The road from obesity to type 2 diabetes.
    Ioannidis I
    Angiology; 2008; 59(2 Suppl):39S-43S. PubMed ID: 18505743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance and inflammation in the early phase of type 2 diabetes: potential for therapeutic intervention.
    Schernthaner GH; Schernthaner G
    Scand J Clin Lab Invest Suppl; 2005; 240():30-40. PubMed ID: 16112958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and the metabolic syndrome.
    Vega GL
    Minerva Endocrinol; 2004 Jun; 29(2):47-54. PubMed ID: 15257255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity; epiphenomenon or cause of metabolic syndrome?
    Lois K; Young J; Kumar S
    Int J Clin Pract; 2008 Jun; 62(6):932-8. PubMed ID: 18479286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adipocytokins, obesity and development of type 2 diabetes].
    Lacquemant C; Vasseur F; Leprêtre F; Froguel P
    Med Sci (Paris); 2005 Dec; 21 Spec No():10-8. PubMed ID: 16598899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is visceral obesity the cause of the metabolic syndrome?
    Després JP
    Ann Med; 2006; 38(1):52-63. PubMed ID: 16448989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance and obesity.
    Greenfield JR; Campbell LV
    Clin Dermatol; 2004; 22(4):289-95. PubMed ID: 15475228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceramides in insulin resistance and lipotoxicity.
    Summers SA
    Prog Lipid Res; 2006 Jan; 45(1):42-72. PubMed ID: 16445986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polycystic ovarian syndrome is a health risk].
    Hippeläinen M
    Duodecim; 2002; 118(10):981-3. PubMed ID: 12238006
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of obesity and adiposity in polycystic ovary syndrome.
    Diamanti-Kandarakis E
    Int J Obes (Lond); 2007 Nov; 31 Suppl 2():S8-13; discussion S31-2. PubMed ID: 17968437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity, metabolic syndrome and sleep apnoea: all pro-inflammatory states.
    Alam I; Lewis K; Stephens JW; Baxter JN
    Obes Rev; 2007 Mar; 8(2):119-27. PubMed ID: 17300278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.